Our purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.
80 Years of Yuyu Pharma
Over 80 years Yuyu has focused on patients and developing new medicines. The company's purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.
Next 100 years, a starting point for a new future.
Noyoung Park appointed as Representative Director
Received Labor-Management Peace Award
Released first generic 'Nagran ODT'
YP-P10, a new drug for the treatment of dry eye, received FDA approval for its Phase 2 clinical trial
Designated by the city of Jecheon, Chungbuk as a “female-friendly workplace
Received an “A” grade evaluation from Korea’s Fair Trade Commission
Yuyu celebrated the 80th anniversary of its establishment
Established collaborative research partnership with UCLA University (USA) for the treatment of multiple sclerosis
Yuyu received certification for its Global Anti-Corruption Management System
Accumulated sales of First Generic Newmacor exceed 40 million capsules
Establishment of new and renewable energy facilities in Jecheon Factory
Introduced to CNN as a social contribution company related to COVID-19
Appointment of CEO Wonsang Yu as president
Establishment of Yuyu Medicals
Appointment of CEO Wonsang Yu
The 100th anniversary of the founder Teckhan Yu's birthday
Selected as Innovative Pharmaceutical Company in Asia Pacific
Seoul office building remodeling completed
Signed MOU with Korean Society of Osteoporosis and Korea Women's Health and Osteoporosis Foundation
Selected as an excellent company for youth jobs in Chungcheongbuk-do
Expansion of the Central Research Center
Released first generic 'Newmacor'
Certified as an excellent family-friendly company by the Ministry of Gender Equality and Family
Awarded a prestigious longevity company by the Ministry of Trade, Industry and Energy
With advanced systems and quality control of global production
Power to innovate management to lay the foundation for a 'second leap'
Selected as an excellent employment company on the 7th Chungbuk Entrepreneur's Day (Governor's Commendation)
Signed export MOU with Huanghua Group in China
Signed LOI with Bio-Pharmaceuticals, Sdn. Bhd. in Malaysia
Exported osteoporosis treatment drug 'Maxmarvil' to Thailand
Marketing using big data for 'Venoplus Gel' is the first of its kind in the Korea pharmaceutical industry
70th anniversary event, Yuyu celebrated the 70th anniversary of its establishment
Released antidepressant over-the-counter drug 'Noiromin'
Release of vitamin C 'YUPANC pop'
Opened Chuncheon Research Center
Release of chronic respiratory infection treatment product 'Umcamin syrup'
'Yuclid' won the Technology Award at the New Drug Development Research Association New Drug Development Awards
Changed company name to Yuyu Pharma
Release of an improved antiplatelet drug 'Yuclid'
Establishment of International Scientific Standard (ISS)
Chairman Seungpil Yu received the Presidential Citation on Taxpayers' Day
Release of intestinal medicine 'Syubaton'
Contract with Swiss Zeller to introduce 'ZE440', a treatment for perimenstrual syndrome
Relocated to the newly-constructed Jecheon Factory
Establishment of Yuyu Healthcare
Establishment of Yuyu Teijin Medicare joint venture
Released an improved new drug for osteoporosis treatment 'Maxmarvil'
Chairman Seungpil Yu received the National Order of Merit, Moran Medal
Seungpil Yu appointed as Chairman of the Korea Pharmaceutical Association
Release of nasal cleanser 'PHYSIOMER'
Management innovation for diversification and globalization President Yoo Seung-pil's inauguration and internationalization strategy.
Technical alliance with Gardo of Argentina (release of osteoporosis treatment 'Mavil tablet')
Obtained manufacturing license for Ginkgo biloba extract for the first time in Korea
Acquired a patent for the manufacturing method of Ginkgo biloba extract
Released 'Solong Capsule', a gastric ulcer treatment with Japan's Taisho
'Tanamin tablet' Germany Dr. Willmar Schwabe with 'EGb761' supply contract, released in Korea
Completion of Seoul office building in Sindang-dong
The release of the biopharmaceutical 'Salbiwon' under an exclusive supply contract with Japan's Kokando
Establishment of the Central Research Center (the 17th accreditation by the Ministry of Science and Technology)
Establishment of Yuyu Calmic, a joint venture with Rentokil of the United Kingdom
Seungpil Yu appointed as President of Yuyu Pharma
Improve by attracting foreign capital, disclosure, and rationalization of management
Challenge to synthesize raw materials such as pars
Technical alliance with Sanofi group of France (release of blood circulation improving agent 'Clid')
Technical alliance with Schwabe of West Germany (release of brain and peripheral circulation improving agent 'Tanamin')
Establishment of Yuyu Fumakilla, a joint venture between Korea and Japan
Technical alliance with Taisho of Japan (release of muscle relaxant 'Rinlaxer')
Changgi Jeon appointed as President of Yuyu Pharma
Adoption of the Chairman-President system. Teckhan Yu appointed as Chairman and Gwangsu Go appointed as President
Technical alliance with Dainippon of Japan (release of anemia treatment 'Burutal Injection')
Technical alliance with Siegteied of Switzerland (release of pain reliever 'Spasla')
Disclosure of enterprises, listing stocks, and establishment of trade unions
Technical partnership with West Germany Dr. Willmar Schwabe (release of a treatment for swelling 'Venoplant')
Technical alliance with Maiji seika of Japan (release of antibiotic 'Maymycin')
Established Yuyu Cultural Foundation
Establishment of Korea Upjohn, a joint venture between Korea and the USA
Technical alliance with Upjohn of the USA (introduced antibiotic new drug 'Lincocin')
Release of 'YUPANC A'
Developed 'Yuyumethionine (DL methionine)' and released 'VENAPOLLO A Soft Capsule'
Development of 'VENAPOLLO', the first soft capsule nutritional supplement in Korea
Released vitamin C formulation 'YUPANC'
It took the lead in establishing 'Yuyu industry' and advancing pharmaceutical technology.
Development of 'Uvita'
Completion of Anyang factory
Changed company name to Yuyu Industrial Co., Ltd.
Produced 'VitaM Tablet', a multivitamin drug for the first time in Korea
Produced 'Furantival tablet', a psychoactive drug
Production of the tuberculosis drug "Eupaszit"
Changed company name to Yuhan Industrial Co., Ltd., purchased its headquarters in Chungmu-ro, Jung-gu, Seoul, and started manufacturing medicine.
A president who is well versed in the health of his fellow countrymen.
Yuyu’s founder, Chairman Teckhan Yu, elected as the fourth Chairman of the Korean Pharmaceutical Industry Association
Founder Teckhan Yu establishes Yuyu Trading Co., Ltd. (Yuyu Pharma)